Synthesis of Methoxy Amido Xanthate Ligand and Preliminary Rhenium-188 Radiolabeling Studies.

Ali Ashrfi Goudarzi, Mehdi Salehi Barough, Leila Moghaddam-Banaem, Saeed Kakaei, Fariba Johari Daha

Abstract read

In one paragraph

Article in Iranian journal of pharmaceutical research : IJPR. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ali Ashrfi GoudarziDepartment of Medical Radiation Engineering, Central Tehran Branch, Islamic Azad University, Tehran, Iran.ORCID https://orcid.org/0000-0002-5680-0002

Mehdi Salehi BaroughDepartment of Medical Radiation Engineering, Central Tehran Branch, Islamic Azad University, Tehran, Iran.ORCID https://orcid.org/0000-0002-5680-0002

Leila Moghaddam-BanaemNuclear Science and Technology Research Institute (NSTRI),School of Nuclear Fuel Cycle, Tehran, Iran.ORCID https://orcid.org/0000-0002-0046-0731

Saeed KakaeiNuclear Science and Technology Research Institute (NSTRI), School of Radiation Application, Tehran, Iran.

Fariba Johari DahaNuclear Science and Technology Research Institute (NSTRI), School of Radiation Application, Tehran, Iran.ORCID https://orcid.org/0000-0002-4395-941X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Rhenium-188 ( Objectives: This study aimed to synthesize and characterize the MAX ligand, optimize its radiolabeling with Methods: The ligand was prepared by reacting chloroacetamide with xanthate derivatives and was characterized using Fourier-transform infrared (FTIR) and nuclear magnetic resonance (NMR) spectroscopy. Radiolabeling was performed using generator-eluted sodium perrhenate ( Results: Under optimal conditions (pH 5 - 6), radiochemical yields exceeding 98% were achieved at 100°C (80 - 100 mCi of Conclusions: A novel MAX ligand was successfully synthesized and radiolabeled with

Indexed as

188ReChelatorMethoxyamido XanthateRadiolabeling

Identifiers

PMID42483085

DOI10.5812/ijpr-171671

PMCPMC13386912

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.